{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:54:33Z","timestamp":1780581273074,"version":"3.54.1"},"reference-count":34,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The management of essential thrombocythemia (ET) relies on risk stratification; therefore, easily applicable risk scores with improved prognostic value are in demand. The Triple A risk score is a novel model incorporating age, absolute neutrophil, and absolute lymphocyte counts (AAA model). In this study, we aimed to evaluate the predictive performance of Triple A score in ET for survival and its complications in an independent cohort, in addition to refining the model by incorporating absolute monocyte count and neutrophil-to-lymphocyte ratio (NLR). Demographic, clinical, and laboratory data of 565 patients with ET were retrospectively collected. Based on Triple A score, 250 patients were classified as low risk, 228 as intermediate-1 risk, 37 as intermediate-2 risk, and 50 as high risk. Over a median follow-up of 6 years, 10.3% patients developed thrombosis, 4.4% experienced bleeding, 5.1% had post-ET myelofibrosis, and 10.9% died. There were significant differences in overall survival and thrombosis-free survival across risk groups. Monocytosis (&amp;gt;0.8 \u00d7 109\/L) was associated with increased mortality and its prevalence increased progressively with higher Triple A scores. Elevated NLR was also linked to a higher risk of mortality, and moreover, NLR-monocyte-age\u2013based risk score demonstrated significant differences in survival risk. Consequently, Triple A score is an easy-to-use and reliable tool for predicting survival and thrombosis in ET. Incorporating monocytosis into Triple A (AAA+A model) may further enhance its prognostic accuracy. NLR also demonstrated prognostic value both independently and as component of NLR-monocyte-age\u2013based model, highlighting its potential as a robust tool for risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017896","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T21:23:57Z","timestamp":1760563437000},"page":"1250-1259","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["A practical tool for predicting outcomes in essential thrombocythemia: Triple A risk model and beyond"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7433-4447","authenticated-orcid":false,"given":"\u00d6zge","family":"S\u00f6nmez","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University Cerrahpa\u015fa, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0590-9985","authenticated-orcid":false,"given":"Esiyla","family":"Oyur","sequence":"additional","affiliation":[{"name":"2Cerrahpa\u015fa Faculty of Medicine, Istanbul University Cerrahpa\u015fa, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3020-850X","authenticated-orcid":false,"given":"\u0130pek","family":"Y\u00f6nal Hindilerden","sequence":"additional","affiliation":[{"name":"3Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Istanbul University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-9555","authenticated-orcid":false,"given":"Fehmi","family":"Hindilerden","sequence":"additional","affiliation":[{"name":"4Division of Hematology, Department of Internal Medicine, Bak\u0131rk\u00f6y Dr Sadi Konuk Training Hospital, Istanbul Health Science University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2176-4371","authenticated-orcid":false,"given":"Mehmet","family":"S\u00f6nmez","sequence":"additional","affiliation":[{"name":"5Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-7501","authenticated-orcid":false,"given":"Abd\u00fclkadir","family":"Kar\u0131\u015fmaz","sequence":"additional","affiliation":[{"name":"6Division of Hematology, Department of Internal Medicine, Istanbul Teaching and Training Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2959-0978","authenticated-orcid":false,"given":"Zeynep","family":"Atl\u0131","sequence":"additional","affiliation":[{"name":"7Department of Statistics, Faculty of Science and Letter, Sinop University, Sinop, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7417-2118","authenticated-orcid":false,"given":"Teoman","family":"Soysal","sequence":"additional","affiliation":[{"name":"8Division of Hematology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University Cerrahpa\u015fa, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9568-0894","authenticated-orcid":false,"given":"Ahmet Emre","family":"E\u015fkazan","sequence":"additional","affiliation":[{"name":"8Division of Hematology, Department of Internal Medicine, Cerrahpa\u015fa Faculty of Medicine, Istanbul University Cerrahpa\u015fa, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"4","key":"2026022411385733500_bib1","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","article-title":"Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel","volume":"110","author":"Tefferi","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2026022411385733500_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4274\/tjh.galenos.2024.2023.0430","article-title":"Impact of CALR and JAK2V617F mutations on clinical course and disease outcomes in essential thrombocythemia: a multicenter retrospective study in Turkish patients","volume":"41","author":"Narl\u0131 \u00d6zdemir","year":"2024","journal-title":"Turk J Haematol"},{"issue":"23","key":"2026022411385733500_bib3","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","article-title":"Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study","volume":"29","author":"Barbui","year":"2011","journal-title":"J Clin Oncol"},{"issue":"22","key":"2026022411385733500_bib4","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMcp1816082","article-title":"Essential thrombocythemia","volume":"381","author":"Tefferi","year":"2019","journal-title":"N Engl J Med"},{"key":"2026022411385733500_bib5","doi-asserted-by":"crossref","first-page":"2634853520978210","DOI":"10.1177\/2634853520978210","article-title":"The essential thrombocythemia in 2020: what we know and where we still have to dig deep","volume":"13","author":"Accurso","year":"2020","journal-title":"Clin Med Insights Blood Disord"},{"issue":"16","key":"2026022411385733500_bib6","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood.2022017625","article-title":"Essential thrombocythemia: challenges in clinical practice and future prospects","volume":"141","author":"Godfrey","year":"2023","journal-title":"Blood"},{"issue":"6","key":"2026022411385733500_bib7","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1182\/blood-2012-01-403279","article-title":"A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment","volume":"120","author":"Passamonti","year":"2012","journal-title":"Blood"},{"issue":"26","key":"2026022411385733500_bib8","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","article-title":"Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)","volume":"120","author":"Barbui","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2026022411385733500_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ajh.24293","article-title":"Validation of the revised International Prognostic Score of thrombosis for essential thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients","volume":"91","author":"Haider","year":"2016","journal-title":"Am J Hematol"},{"issue":"9","key":"2026022411385733500_bib9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.6004\/jnccn.2022.0046","article-title":"Myeloproliferative neoplasms, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gerds","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"2026022411385733500_bib11","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/ajh.27079","article-title":"A globally applicable \u201ctriple A\u201d risk model for essential thrombocythemia based on age, absolute neutrophil count, and absolute lymphocyte count","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am J Hematol"},{"issue":"12","key":"2026022411385733500_bib12","doi-asserted-by":"crossref","first-page":"e1916526","DOI":"10.1001\/jamanetworkopen.2019.16526","article-title":"Association of lymphopenia with risk of mortality among adults in the US general population","volume":"2","author":"Zidar","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"13","key":"2026022411385733500_bib13","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","article-title":"Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas","volume":"69","author":"Ray-Coquard","year":"2009","journal-title":"Cancer Res"},{"issue":"3","key":"2026022411385733500_bib14","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s11357-023-01034-7","article-title":"Neutrophil, lymphocyte count, and neutrophil to lymphocyte ratio predict multimorbidity and mortality-results from the Baltimore longitudinal study on aging follow-up study","volume":"46","author":"Pellegrino","year":"2024","journal-title":"Geroscience"},{"key":"2026022411385733500_bib15","doi-asserted-by":"crossref","first-page":"1415804","DOI":"10.3389\/fimmu.2024.1415804","article-title":"Increased neutrophil counts are associated with poor overall survival in patients with colorectal cancer: a five-year retrospective analysis","volume":"15","author":"Garcia-Flores","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"2026022411385733500_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41408-023-00972-x","article-title":"One thousand patients with essential thrombocythemia: the Mayo Clinic experience","volume":"14","author":"Gangat","year":"2024","journal-title":"Blood Cancer J"},{"issue":"2","key":"2026022411385733500_bib17","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1002\/ajh.26423","article-title":"Deciphering the individual contribution of absolute neutrophil and monocyte counts to thrombosis risk in polycythemia vera and essential thrombocythemia","volume":"97","author":"Farrukh","year":"2022","journal-title":"Am J Hematol"},{"issue":"13","key":"2026022411385733500_bib18","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","article-title":"Myeloproliferative neoplasms and thrombosis","volume":"122","author":"Barbui","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2026022411385733500_bib19","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.3390\/ijms23063206","article-title":"Thromboinflammation in myeloproliferative neoplasms (MPN)\u2014a puzzle still to be solved","volume":"23","author":"Bhuria","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026022411385733500_bib20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41598-020-79431-7","article-title":"Neutrophil-to-lymphocyte ratio and mortality in the United States general population","volume":"11","author":"Song","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"2026022411385733500_bib21","doi-asserted-by":"crossref","first-page":"e35638","DOI":"10.1002\/cncr.35638","article-title":"Neutrophil-to-lymphocyte ratio (NLR) at diagnosis in essential thrombocythemia: a new promising predictor of thrombotic events","volume":"131","author":"Ripamonti","year":"2025","journal-title":"Cancer"},{"issue":"1","key":"2026022411385733500_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41408-024-00994-z","article-title":"Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study","volume":"14","author":"Larsen","year":"2024","journal-title":"Blood Cancer J"},{"issue":"suppl 1","key":"2026022411385733500_bib23","first-page":"875","article-title":"Monocyte-driven aberrant inflammation in myeloproliferative neoplasms is regulated by galectin-1","volume":"144","author":"Galectin","year":"2024","journal-title":"Blood"},{"issue":"7","key":"2026022411385733500_bib24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/07357907.2024.2371371","article-title":"Myeloproliferative neoplasms transcriptome reveals pro-inflammatory signature and enrichment in peripheral blood monocyte-related genes","volume":"42","author":"Bassan","year":"2024","journal-title":"Cancer Invest"},{"issue":"5","key":"2026022411385733500_bib25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjh.15061","article-title":"Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis","volume":"183","author":"Tefferi","year":"2018","journal-title":"Br J Haematol"},{"issue":"7","key":"2026022411385733500_bib26","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ajh.24740","article-title":"Monocytosis in polycythemia vera: clinical and molecular correlates","volume":"92","author":"Barraco","year":"2017","journal-title":"Am J Hematol"},{"issue":"4","key":"2026022411385733500_bib27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026022411385733500_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41408-024-01151-2","article-title":"The Triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia","volume":"14","author":"Tosoni","year":"2024","journal-title":"Blood Cancer J"},{"issue":"suppl 1","key":"2026022411385733500_bib29","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1182\/blood-2024-193907","article-title":"Monocytosis is an independent risk factor for survival in essential thrombocythemia - a revised Triple-a prognostic score (AAA+A) based on age and absolute monocyte, neutrophil, and lymphocyte counts","volume":"144","author":"Tefferi","year":"2024","journal-title":"Blood"},{"key":"2026022411385733500_bib30","author":"Cavalca","year":"12-15  2025"},{"issue":"11","key":"2026022411385733500_bib31","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ajh.70065","article-title":"Triple A plus (AAA+) survival prediction model for essential thrombocythemia: analysis involving 7308 patients","volume":"100","author":"Tefferi","year":"2025  3","journal-title":"Am J Hematol"},{"issue":"6","key":"2026022411385733500_bib32","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/bjh.19813","article-title":"Neutrophil\/lymphocyte ratio identifies low-risk polycythaemia vera patients for early ropeginterferon alfa-2b therapy","volume":"205","author":"Barbui","year":"2024","journal-title":"Br J Haematol"},{"issue":"1","key":"2026022411385733500_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41408-025-01317-6","article-title":"Neutrophil-to-Lymphocyte ratio as surrogate for JAK2V617F suppression and event-free survival in polycythemia vera","volume":"15","author":"Barbui","year":"2025","journal-title":"Blood Cancer J"},{"issue":"2","key":"2026022411385733500_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41408-022-00625-5","article-title":"Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera","volume":"12","author":"Carobbio","year":"2022","journal-title":"Blood Cancer J"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/4\/1250\/2503856\/blooda_adv-2025-017896-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/4\/1250\/2503856\/blooda_adv-2025-017896-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:39:05Z","timestamp":1771951145000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/4\/1250\/547808\/A-practical-tool-for-predicting-outcomes-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017896","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,24]]},"published":{"date-parts":[[2026,2,13]]}}}